

Scientists looking at potential pharmaceuticals to help people recover from spinal cord injuries have discovered a promising path to new treatments.
Researchers investigated over 1,000 possible medications and discovered that an already available one, cimetidine, boosted spinal healing in zebrafish.
When tested in spine-injured animals, the medication also improved mobility recovery and reduced the extent of spinal cord damage.
Experts claim the findings, which have been published in the journal Theranostics, give fresh light on the biochemical mechanisms involved in spinal cord injury rehabilitation.
Sudden strikes on the spinal cord, such as those induced by a car collision, can result in permanent injury.
Inflammation generated by an overreaction of the body’s immune system, which normally protects against infections, can make healing inefficient.
Anti-inflammatory drugs that decrease the entire immune response also block immunological cells that facilitate healing.
Multiple medications were examined in zebrafish larvae for their capacity to reduce excessive inflammation during an immunological response in a study headed by the University of Edinburgh.
Cimetidine works by helping to manage histamine levels in the body, which is a substance secreted by the immune system that is implicated in inflammatory reactions, according to researchers.
The findings allowed the researchers to identify a unique signaling route that moderates the immune response after spinal damage to aid in recovery.
Model of a zebrafish
Other medications that function in a similar way, according to experts, could be studied for their ability to aid recovery from spinal injury. However, they warn that further research is needed to explore their impact in human clinical trials.
According to the researchers, the study demonstrates the utility of zebrafish in the drug discovery process.
The research team included experts from the University of Edinburgh, the McGill University Health Centre Research Institute, and Technische Universität Dresden.
The ability to screen a large number of drugs using the zebrafish model has revealed an important target for future research into spinal cord repair. Our findings open the door to potential new treatments that can moderate inflammation and improve recovery from spinal injury,” said Professor Catherina Becker
more recommended stories
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear Treatment
Meniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Toxic Soil and Water Linked to Global Heart Disease Crisis
A groundbreaking review published in Atherosclerosis.
Leave a Comment